Jane Street Group, LLC Ironwood Pharmaceuticals Inc Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 323,638 shares of IRWD stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
323,638
Previous 159,632 102.74%
Holding current value
$1.14 Million
Previous $1.04 Million 27.88%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.93 - $7.04 $644,543 - $1.15 Million
164,006 Added 102.74%
323,638 $1.33 Million
Q2 2024

Aug 14, 2024
BUY
$5.58 - $8.61 $514,197 - $793,411
92,150 Added 136.55%
159,632 $1.04 Million
Q1 2024

May 15, 2024
SELL
$8.32 - $15.45 $1.91 Million - $3.54 Million
-229,429 Reduced 77.27%
67,482 $587,000
Q4 2023

Feb 14, 2024
SELL
$8.79 - $11.51 $1.91 Million - $2.5 Million
-217,586 Reduced 42.29%
296,911 $3.4 Million
Q3 2023

Nov 14, 2023
BUY
$8.25 - $11.35 $2.37 Million - $3.26 Million
286,983 Added 126.14%
514,497 $4.95 Million
Q2 2023

Aug 14, 2023
SELL
$10.1 - $11.6 $17.2 Million - $19.7 Million
-1,698,368 Reduced 88.19%
227,514 $2.42 Million
Q1 2023

May 15, 2023
BUY
$10.37 - $12.56 $18.5 Million - $22.4 Million
1,783,342 Added 1251.12%
1,925,882 $20.3 Million
Q4 2022

Feb 14, 2023
BUY
$9.9 - $12.43 $890,079 - $1.12 Million
89,907 Added 170.82%
142,540 $1.77 Million
Q3 2022

Nov 14, 2022
SELL
$10.14 - $12.38 $1.92 Million - $2.34 Million
-189,395 Reduced 78.25%
52,633 $545,000
Q3 2022

Nov 14, 2022
SELL
$10.14 - $12.38 $1.92 Million - $2.34 Million
-189,395 Reduced 78.25%
52,633 $545,000
Q2 2022

Aug 16, 2022
BUY
$11.05 - $12.72 $1.6 Million - $1.85 Million
145,073 Added 149.63%
242,028 $2.79 Million
Q1 2022

May 17, 2022
SELL
$10.61 - $12.88 $280,125 - $340,057
-26,402 Reduced 21.4%
96,955 $1.22 Million
Q4 2021

Feb 15, 2022
SELL
$10.86 - $13.95 $2.21 Million - $2.85 Million
-203,944 Reduced 62.31%
123,357 $1.44 Million
Q3 2021

Nov 16, 2021
BUY
$11.92 - $13.92 $2.19 Million - $2.56 Million
183,700 Added 127.92%
327,301 $4.27 Million
Q2 2021

Aug 16, 2021
BUY
$10.16 - $13.11 $799,175 - $1.03 Million
78,659 Added 121.12%
143,601 $1.85 Million
Q1 2021

May 18, 2021
BUY
$9.04 - $11.86 $57,431 - $75,346
6,353 Added 10.84%
64,942 $726,000
Q4 2020

Feb 17, 2021
SELL
$9.05 - $12.2 $235,843 - $317,932
-26,060 Reduced 30.79%
58,589 $667,000
Q3 2020

Nov 17, 2020
BUY
$8.99 - $10.74 $477,054 - $569,918
53,065 Added 168.01%
84,649 $761,000
Q2 2020

Aug 17, 2020
BUY
$9.14 - $11.97 $288,677 - $378,060
31,584 New
31,584 $326,000
Q4 2019

Feb 14, 2020
SELL
$8.22 - $14.0 $157,207 - $267,750
-19,125 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$8.59 - $10.96 $164,283 - $209,610
19,125 New
19,125 $164,000
Q1 2019

May 16, 2019
SELL
$8.27 - $12.73 $604,313 - $930,219
-73,073 Closed
0 $0
Q4 2018

Feb 15, 2019
BUY
$7.8 - $16.13 $569,969 - $1.18 Million
73,073 New
73,073 $757,000
Q2 2018

Aug 15, 2018
SELL
$11.83 - $16.2 $138,056 - $189,054
-11,670 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$11.13 - $13.63 $68,093 - $83,388
-6,118 Reduced 34.39%
11,670 $180,000
Q4 2017

Feb 15, 2018
SELL
$12.16 - $14.58 $31,555 - $37,835
-2,595 Reduced 12.73%
17,788 $267,000
Q3 2017

Nov 14, 2017
BUY
$12.07 - $14.87 $246,022 - $303,095
20,383
20,383 $321,000

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email